Related references
Note: Only part of the references are listed.Improved Antibiotic Prescribing within a Veterans Affairs Primary Care System through a Multifaceted Intervention Centered on Peer Comparison of Overall Antibiotic Prescribing Rates
Nathan R. Shively et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Sustained Reductions in Overall and Unnecessary Antibiotic Prescribing at Primary Care Clinics in a Veterans Affairs Healthcare System Following a Multifaceted Stewardship Intervention
Deanna J. Buehrle et al.
CLINICAL INFECTIOUS DISEASES (2020)
Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative
Kevin Lin et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
Deanna J. Buehrle et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Kasper Iversen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Oral versus Intravenous Antibiotics for Bone and Joint Infection
H. -K. Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections
Kevin Cowart et al.
ANNALS OF PHARMACOTHERAPY (2019)
Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals
Michael E. Yarrington et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)
Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study
Kao-Ping Chua et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits
Sarah Kabbani et al.
CLINICAL INFECTIOUS DISEASES (2018)
Improving fluoroquinolone use in the outpatient setting using a patient safety initiative
Kazuaki Jindai et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)
Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010-2015
Katie J. Suda et al.
CLINICAL INFECTIOUS DISEASES (2018)
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991-2015
Ziyad S. Almalki et al.
PHARMACOECONOMICS-OPEN (2017)
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Nadine Shehab et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Share Paper
